Intrinsic Value

The intrinsic value of Malin Corporation PLC (MLC) under the Base Case is 7.87 EUR per share. Compared with the current market price of 5.95 EUR, the stock appears Undervalued by 24% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

MLC Intrinsic Value
€7.87
Undervaluation 24%
Intrinsic Value
Price €5.95

MLC is valued in line with its history. A discount of this size has been typical over the past 4 years.

Monitor MLC
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €6.3
Get notified when the price drops into your buy zone
Intrinsic Value €7.87
Margin of Safety 20% €6.3
Current Price €5.95
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MLC

Fundamental Analysis

What Malin Does

Life Sciences Tools & Services Health Care

Malin Corporation PLC is an investment company that owns stakes in healthcare and life sciences businesses rather than selling medicines or medical products itself. It looks for companies developing drugs, devices, diagnostics, or related technologies, then helps support them financially and strategically as they grow.

Headquarters
Ireland IE
Employees
5
IPO date
Mar 25, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Malin Corporation PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one MLC stock?

The intrinsic value for Malin Corporation PLC (MLC) under the Base Case is 7.87 EUR.

Is MLC stock undervalued or overvalued?

Compared with the current market price of 5.95 EUR, the stock appears Undervalued by 24% .

Back to Top